|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-5-7
|
|
pubmed:abstractText |
A furazolidone-containing therapeutic regimen for Helicobacter pylori infection has attracted special interest in the face of a rising world-wide metronidazole resistant H. pylori, and the expense of currently used antimicrobial regimens.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo...,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents, Local,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin,
http://linkedlifedata.com/resource/pubmed/chemical/Furazolidone,
http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole,
http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/bismuth tripotassium dicitrate,
http://linkedlifedata.com/resource/pubmed/chemical/lansoprazole
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
317-22
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10102964-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:10102964-Adult,
pubmed-meshheading:10102964-Anti-Bacterial Agents,
pubmed-meshheading:10102964-Anti-Infective Agents, Local,
pubmed-meshheading:10102964-Anti-Ulcer Agents,
pubmed-meshheading:10102964-Clarithromycin,
pubmed-meshheading:10102964-Drug Therapy, Combination,
pubmed-meshheading:10102964-Duodenal Ulcer,
pubmed-meshheading:10102964-Dyspepsia,
pubmed-meshheading:10102964-Female,
pubmed-meshheading:10102964-Follow-Up Studies,
pubmed-meshheading:10102964-Furazolidone,
pubmed-meshheading:10102964-Helicobacter Infections,
pubmed-meshheading:10102964-Helicobacter pylori,
pubmed-meshheading:10102964-Humans,
pubmed-meshheading:10102964-Male,
pubmed-meshheading:10102964-Middle Aged,
pubmed-meshheading:10102964-Omeprazole,
pubmed-meshheading:10102964-Organometallic Compounds
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection.
|
|
pubmed:affiliation |
Shanghai Institute of Digestive Disease, Shanghai Second Medical University, Shanghai, China.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
